Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

3006 PWToday Stories

SK Life Science selects Patheon as development partner for CNS drug program

09 Jul 08

SK Life Science, the US-based subsidiary of Korean SK Holdings, has selected Patheon as their development services partner for two additional innovative central nervous system drug candidates.

Patheon will provide formulation and analytical development services as well as clinical supplies for one of the CNS candidates in multiple dosage forms for SK Life Science's advanced clinical studies.

In addition, Patheon will provide development and clinical materials manufacturing services for another CNS candidate in Phase I clinical trials.

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.